Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

Clinical trial NCT04869943 · TERMINATED

Trial details

NCT number: NCT04869943
Sponsor: Veru Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2021-10-12
Primary completion: 2024-01-09
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.